[Federal Register Volume 85, Number 197 (Friday, October 9, 2020)]
[Notices]
[Page 64152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22370]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing; 
Correction

AGENCY: National Institutes of Health, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services, National 
Institutes of Health published a Notice in the Federal Register on 
October 1, 2020. That Notice requires a correction in the SUPPLEMENTARY 
INFORMATION section.

FOR FURTHER INFORMATION CONTACT: Amy F. Petrik, Ph.D., licensing 
contact, 240-627-3721; [email protected]. Licensing information and 
copies of the U.S. patent application may be obtained by communicating 
with the licensing contact at the Technology Transfer and Intellectual 
Property Office, National Institute of Allergy and Infectious Diseases, 
5601 Fishers Lane, Rockville, MD 20852; tel. 301-496-2644. A signed 
Confidential Disclosure Agreement will be required to receive copies of 
unpublished patent applications.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of October 1, 2020, in FR Doc. 2020-21708, 
on page 61961, as found within the SUPPLEMENTARY INFORMATION section. 
The title of the invention, currently reads ``Structure-Based Design of 
SARS2-CoV-2 Spike Immunogens Stabilized in the RBD-All Down 
Conformation'' and should read ``Structure-Based Design of SARS-CoV-2 
Spike Immunogens Stabilized in the RBD-All Down Conformation''.

    Dated: October 5, 2020.
Daniel R Hernandez,
Federal Register Officer, National Institutes of Health.
[FR Doc. 2020-22370 Filed 10-8-20; 8:45 am]
BILLING CODE 4140-01-P